Lymphoma survivor recognized for helping Denver cancer patients

October 13, 2005

The American Society for Therapeutic Radiology and Oncology has named John Erik Anduri of Denver as the 2005 Survivor Circle Award Winner. Mr. Anduri will be presented with this award and cash prize on Monday, October 17 at 7 p.m., at the National Western Complex during ASTRO's 47th Annual Scientific Meeting being held in Denver October 16-20.

The Survivor Circle Award was created this year as a way to recognize a cancer survivor in the metropolitan Denver area who has dedicated his or her time and energy to helping others in the local community. Mr. Anduri was diagnosed with Hodgkin's disease in 1975 at the age of 22. He took this difficult diagnosis and turned it into a wonderful effort to help others who are suffering. He volunteers for CanSurmount, where he makes home and hospital visits to newly diagnosed cancer patients and their families to offer them support, insight and encouragement. He is also very active with the National Coalition for Cancer Survivorship in Denver as well as the American Cancer Society's Denver Chapter.

"It is refreshing to see someone take the difficult diagnosis of cancer and turn it into an opportunity to help those who are going through the same thing," said Prabhakar Tripuraneni, M.D., ASTRO President. "Mr. Anduri is a 30 year cancer survivor who has shown that good can come out of such an experience. His volunteerism is a testament his generous spirit."

The Survivor Circle was established in 2003 as a way for ASTRO to give back to the cities visited during the Society's Annual Meeting. Each year, ASTRO partners with two local organizations to build relationships between patient advocacy organizations and radiation oncologists as well as raise money to support the work these groups do to help people living with cancer and their families. One hundred percent of the proceeds raised through the Survivor Circle are given to the groups. This year the ASTRO has partnered with Gilda's Club Denver and Ronald McDonald House Charities of Denver, Inc.

The ASTRO Annual Meeting is considered the premier scientific meeting in radiation oncology and attracts oncologists of all disciplines, physicists, nurses, biologists and other health care professionals from throughout the world. The theme of this year's meeting is "Expanding the Horizons of Radiation Therapy" and the program will highlight emerging and innovative technologies, biological modifiers and systemic targeted radiotherapy with practical applications affecting the lives of cancer patients both today and tomorrow.

For more information on Survivor Circle, the Survivor Circle Award or ASTRO's 47th Annual Meeting, please visit http://www.astro.org/annual_meeting/index.htm. For more information on radiation therapy, visit www.rtanswers.org.
-end-
ASTRO is the largest radiation oncology society in the world, with more than 8,000 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment.

American Society for Radiation Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.